June 23, 2017 10:45 PM ET

Biotechnology

Company Overview of Vaxart, Inc.

Company Overview

Vaxart, Inc. develops oral recombinant enteric-coated tablet vaccines based on its proprietary oral vaccine delivery platform. The company’s platform is suitable to deliver various recombinant protein antigens, such as those used in influenza, hepatitis B, and human papilloma virus (HPV) vaccines, as well as other recombinant vaccines. Its products include Ebola and H1N1 influenza vaccines; vaccines to protect against pathogens, such as avian influenza or biodefense threats; prophylactic and therapeutic vaccines; and norovirus tablet vaccines. The company was formerly known as West Coast Biologicals, Inc. Vaxart, Inc. was founded in 2004 and is based in South San Francisco, California.

385 Oyster Point Boulevard

Suite 9A

South San Francisco, CA 94080

United States

Founded in 2004

Phone:

650-550-3500

Fax:

650-871-8580

Key Executives for Vaxart, Inc.

Chief Executive Officer and Director
Founder, Chief Scientific Officer and Director
Chief Financial Officer
Age: 64
Chief Medical Officer
Senior Vice President of Corporate Development and Strategy
Age: 47
Compensation as of Fiscal Year 2016.

Vaxart, Inc. Key Developments

Vaxart, Inc. Presents at Jefferies 2017 Global Healthcare Conference, Jun-07-2017 11:30 AM

Vaxart, Inc. Presents at Jefferies 2017 Global Healthcare Conference, Jun-07-2017 11:30 AM. Venue: Grand Hyatt, 109 E 42nd St, New York, New York, United States. Speakers: Samir P. Singh, Senior Vice President of Corporate Development and Strategy, Wouter W. Latour, Chief Executive Officer and Director.

Vaxart, Inc. Presents at 16th Annual Needham Healthcare Conference, Apr-05-2017 01:40 PM

Vaxart, Inc. Presents at 16th Annual Needham Healthcare Conference, Apr-05-2017 01:40 PM. Venue: Westin Grand Central Hotel, New York, New York, United States.

Vaxart, Inc. Presents at Sachs Associates 10th Annual European Life Sciences CEO Forum & Exhibition, Mar-06-2017 through Mar-07-2017

Vaxart, Inc. Presents at Sachs Associates 10th Annual European Life Sciences CEO Forum & Exhibition, Mar-06-2017 through Mar-07-2017. Venue: Hilton Zurich Airport Hotel, Hohenbuehlstrasse 10, Opfikon-Glattbrugg 8152 Zurich, Switzerland. Presentation Date & Speakers: Mar-06-2017, Wouter W. Latour, Chief Executive Officer and Director.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3Bar Biologics Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
The Advertising Council, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Vaxart, Inc., please visit www.vaxart.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.